FGAM
AMRX icon

Financial Gravity Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Financial Gravity Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$1K Sell
82
-20
-20% -$421 ﹤0.01% 1067
2018
Q2 		$2K Buy
+102
New +$1.79K ﹤0.01% 950

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return

Financial Gravity Asset Management's AMRX Position: Q3 2018 in Review

Financial Gravity Asset Management reduced its Amneal Pharmaceuticals (AMRX) stake by 20% in Q3 2018, selling an estimated $421 and leaving 82 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Financial Gravity Asset Management first reported a position in AMRX in Q2 2018 and has held it in 2 quarters since. The position peaked at $2K in Q2 2018. 167 funds tracked by Wall St. Rank hold AMRX as of Q3 2018.

  • Financial Gravity Asset Management held 82 shares of Amneal Pharmaceuticals worth $1K as of Q3 2018.
  • Financial Gravity Asset Management sold 20 Amneal Pharmaceuticals shares in Q3 2018, an estimated $421.
  • Amneal Pharmaceuticals made up ﹤0.01% of Financial Gravity Asset Management's portfolio in Q3 2018, its #1067 holding.
  • Financial Gravity Asset Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 2 quarters since.
  • Financial Gravity Asset Management's Amneal Pharmaceuticals position peaked at $2K in Q2 2018.
  • 167 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2018.

Based on Financial Gravity Asset Management's 13F filing for Q3 2018, filed 31 Oct 2018.